Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 2 hours ago
GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug
about 2 hours ago
Like Merck & Co.’s PAH drug Winrevair—which brought in $1.4 billion last...
Werewolf weighs sale or merger as cash reserves whimper
about 14 hours ago
With its cash cache set to run out by the fourth quarter...
After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst
about 14 hours ago
The average upfront value for a licensing deal between a Western biotech...
Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal
about 17 hours ago
Harbour BioMed is setting sail as the Solstice begins, riding the waves...
FDA freezes enrollment in MacroGenics cancer trial after patient death
about 17 hours ago
The FDA has ordered MacroGenics to halt enrollment in a phase 2...
Evinova reels in AI clinical development deals with Astellas and AstraZeneca
about 18 hours ago
Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by partnering with...
Medtronic's diabetes business MiniMed eyes $784M IPO
about 22 hours ago
Less than a year after announcing the spinout of its diabetes division...
Allurion stock balloons as FDA signs off on its weight loss gastric system
about 22 hours ago
Allurion saw its shares jump roughly 60% on Monday, Feb. 23, as...
Abcuro’s KLRG1 antibody flunks phase 2/3 muscle disease study
about 22 hours ago
A year after Abcuro raised $200 million to fund a phase 2/3...
Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics
about 23 hours ago
Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology...
GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech
about 23 hours ago
GSK is continuing to bolster its siRNA portfolio by paying $40 million...
Novo Nordisk’s triple G candidate drives 20% weight loss in phase 2 trial in China
about 23 hours ago
Novo Nordisk and its Chinese partner have reported up to 19.7% weight...